Evidence map›Paper›PMID 26120935›Full record

ArticleTissue engineering. Part A2015

PI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System.

Kujaany Kana, Hannah Song, Carol Laschinger, Peter W Zandstra, Milica Radisic

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kujaany Kana1 Institute of Biomaterials and Biomedical Engineering , Toronto, Canada .
Hannah Song1 Institute of Biomaterials and Biomedical Engineering , Toronto, Canada .
Carol Laschinger2 Department of Chemical Engineering and Applied Chemistry, University of Toronto , Canada .
Peter W Zandstra1 Institute of Biomaterials and Biomedical Engineering , Toronto, Canada .
Milica Radisic1 Institute of Biomaterials and Biomedical Engineering , Toronto, Canada .
University of Toronto · CA

Funding

Engineering Vascularized Cardiac MuscleR01HL076485 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Gordana Vunjak-Novakovic · 2005 to 2026
$9.2M
Canadian Institutes of Health Research MOP-126027NHLBI NIH HHS R01 HL076485
6 · The paper itself

Abstract

Myocardial infarction, a prevalent cardiovascular disease, is associated with cardiomyocyte cell death, and eventually heart failure. Cardiac tissue engineering has provided hopes for alternative treatment options, and high-fidelity tissue models for drug discovery. The signal transduction mechanisms relayed in response to mechanoelectrical (physical) stimulation or biochemical stimulation (hormones, cytokines, or drugs) in engineered heart tissues (EHTs) are poorly understood. In this study, an EHT model was used to elucidate the signaling mechanisms involved when insulin was applied in the presence of electrical stimulation, a stimulus that mimics functional heart tissue environment in vitro. EHTs were insulin treated, electrically stimulated, or applied in combination (insulin and electrical stimulation). Electrical excitability parameters (excitation threshold and maximum capture rate) were measured. Protein kinase B (AKT) and phosphatidylinositol-3-kinase (PI3K) phosphorylation revealed that insulin and electrical stimulation relayed electrical excitability through two separate signaling cascades, while there was a negative crosstalk between sustained activation of AKT and PI3K.

Indexed as

Electrophysiological PhenomenaAnimalsAnimals, NewbornBenzenesulfonamidesChlorpropamideChromonesDisease Models, AnimalGene Expression ProfilingGene Expression RegulationHeartInsulinModels, BiologicalMorpholinesMyocytes, CardiacPhosphatidylinositol 3-KinasePhosphorylation2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAPI 2BenzenesulfonamidesChlorpropamideChromonesInsulinMorpholinesPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-akt

Identifiers

PMID26120935
PMCPMC4559196
OpenAlexW2179438646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.